SCHEMBL2823404

SCHEMBL2823404

C=NOCCCC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5958099 0.92
SCHEMBL8614311 0.89 TSHR (0.42)
SCHEMBL6571777 0.89
SCHEMBL8613327 0.89 TSHR (0.42)
SCHEMBL8617990 0.89 TSHR (0.42)
SCHEMBL8616144 0.89 TSHR (0.42)
Ethylamine SCHEMBL9461012 0.83 DNM1 (0.42)
SCHEMBL630936 0.81
Ethylamine SCHEMBL9620524 0.81 DNM1 (0.41)
Pyridine SCHEMBL9694965 0.76 LMNA (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113354557-A Preparation method and application of 3-phenyl-2-propylene-1-one O-n-butyl oxime 大连理工大学 2021-09-07 CN claimed
US-6933302-B2 Nitrogen-based homo-camptothecin derivatives CALIFORNIA PACIFIC MEDICAL CENTER (US) 2005-08-23 US claimed
US-6855720-B2 Nitrogen-based camptothecin derivatives CALIFORNIA PACIFIC MEDICAL CENTER (US) 2005-02-15 US claimed
US-20040063740-A1 For treatment of cancer SUTTER WEST BAY HOSPITALS, DBA CALIFORNIA PACIFIC MEDICAL CENTER 2004-04-01 US claimed
US-20040034050-A1 Homo-camptothecin derivatives CATHOLIC HEALTHCARE WEST, DOING BUSINESS AS ST. MARY'S MEDICAL CENTER OF SAN FRANCISCO 2004-02-19 US claimed
WO-2003101998-A1 NITROGEN-BASED HOMO-CAMPTOTHECIN DERIVATIVES CALIFORNIA PACIFIC MEDICAL CENTER (US) 2003-12-11 WO claimed
WO-2003101406-A1 HOMO-CAMPTOTHECIN DERIVATIVES CALIFORNIA PACIFIC MEDICAL CENTER (US) 2003-12-11 WO claimed
US-20030032624-A1 Nitrogen-based camptothecin derivatives US ARMY, SECRETARY OF THE ARMY 2003-02-13 US claimed
WO-2022253283-A1 PROTEIN KINASE DEGRADANT AND USE THEREOF 中国科学院上海有机化学研究所 2022-12-08 WO disclosed
CN-113354557-B Preparation method and application of 3-phenyl-2-propylene-1-one O-n-butyl oxime 大连理工大学 2022-06-28 CN disclosed
CN-113354557-A Preparation method and application of 3-phenyl-2-propylene-1-one O-n-butyl oxime 大连理工大学 2021-09-07 CN disclosed
US-20170000132-A1 BENZOXABOROLE FUNGICIDES SYNGENTA PARTICIPATIONS AG (CH) 2017-01-05 US disclosed
US-20170000132-A1 BENZOXABOROLE FUNGICIDES SYNGENTA PARTICIPATIONS AG (CH) 2017-01-05 US disclosed
US-20150315146-A1 USE OF SUBSTITUTED 1-(ARYL ETHYNYL)-, 1-(HETEROARYL ETHYNYL)-, 1-(HETEROCYCLYL ETHYNYL)- AND 1-(CYCLOALKENYLETHYNYL)-BICYCLOALKANOLS AS ACTIVE AGENTS AGAINST ABIOTIC PLANT STRESS BAYER CROPSCIENCE AG (DE) 2015-11-05 US disclosed
US-5254717-A Imino-substituted phenyl derivatives, the preparation thereof and fungicides containing these BASF AKTIENGESELLSCHAFT (DE) 1993-10-19 US disclosed
EP-0499823-A2 Imino-substituted phenyl derivatives, their preparation and fungicides containing them BASF Aktiengesellschaft (DE) 1992-08-26 EP disclosed
EP-0463488-A1 O-Benzyl oxime ethers and fungicides containing them BASF Aktiengesellschaft (DE) 1992-01-02 EP disclosed
US-5037976-A Antimicrobial Agent OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1991-08-06 US disclosed
US-4898859-A 2-Oxa-isocephem compounds and compositions containing same OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1990-02-06 US disclosed
EP-0282895-A2 2-oxa-isocephem compounds, compositions containing same and processes for preparing same OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1988-09-21 EP disclosed